These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1651310)

  • 1. Halogenated pyrimidines as radiosensitizers for high grade glioma: revisited.
    Rodriguez R; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):859-62; discussion 865. PubMed ID: 1651310
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of the combined use of radiosensitizing agents on radiotherapy of malignant encephaloma].
    Hoshino T
    Rinsho Hoshasen; 1968 Nov; 13(11):885-91. PubMed ID: 4304555
    [No Abstract]   [Full Text] [Related]  

  • 3. Halogenated pyrimidines as radiosensitizers in the treatment of glioblastoma multiforme.
    Jackson D; Kinsella T; Rowland J; Wright D; Katz D; Main D; Collins J; Kornblith P; Glatstein E
    Am J Clin Oncol; 1987 Oct; 10(5):437-43. PubMed ID: 2821790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour radiosensitization with the halogenated pyrimidines 5'-bromo- and 5'-iododeoxyuridine.
    Epstein AH; Cook JA; Goffman T; Glatstein E
    BJR Suppl; 1992; 24():209-14. PubMed ID: 1290703
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: Hypoxic cell radiosensitizers.
    Belli JA; Hellman S
    N Engl J Med; 1976 Jun; 294(25):1399-400. PubMed ID: 177876
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study.
    Phillips TL; Levin VA; Ahn DK; Gutin PH; Davis RL; Wilson CB; Prados MD; Wara WM; Flam MS
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):709-14. PubMed ID: 1651306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of postoperative treatment of glioblastoma multiforme with a radiation-sensitizing substance (5-bromo-2-deoxyuridine)].
    Landolt AM
    Acta Neurochir (Wien); 1971; 24(4):263-8. PubMed ID: 4332090
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and experimental results of interstitial Curie-therapy combined with radiosensitizing agents in DS carcinoma of the rat and in infiltrating brain neoplasms].
    Mundinger F
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:201. PubMed ID: 4341101
    [No Abstract]   [Full Text] [Related]  

  • 10. Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas.
    Hegarty TJ; Thornton AF; Diaz RF; Chandler WF; Ensminger WD; Junck L; Page MA; Gebarski SS; Hood TW; Stetson PL
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):421-8. PubMed ID: 2168357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non-hypoxic cell sensitizers.
    Kinsella TJ; Mitchell JB; Russo A; Morstyn G; Glatstein E
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1399-406. PubMed ID: 6381432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy in the treatment of malignant glioma.
    Kim RY; Langford KH; Roth RE
    J Med Assoc State Ala; 1977 Oct; 47(4):39-41. PubMed ID: 200689
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiation plus metronidazole for glioblastoma.
    Urtasun RC; Band PR; Chapman JD; Feldstein ML
    N Engl J Med; 1977 Mar; 296(13):757. PubMed ID: 190541
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of BAR therapy in a case of malignant glioma with extracranial metastasis].
    Kanno T; Moriyama M; Kagawa M; To T; Ishimori S
    No To Shinkei; 1970 Oct; 22(10):1187-91. PubMed ID: 5536188
    [No Abstract]   [Full Text] [Related]  

  • 15. A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.
    Kinsella TJ; Russo A; Mitchell JB; Rowland J; Jenkins J; Schwade J; Myers CE; Collins JM; Speyer J; Kornblith P
    Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):69-76. PubMed ID: 6321412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.
    Groves MD; Maor MH; Meyers C; Kyritsis AP; Jaeckle KA; Yung WK; Sawaya RE; Hess K; Bruner JM; Peterson P; Levin VA
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):127-35. PubMed ID: 10477016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
    Sano K; Hoshino T; Nagai M
    J Neurosurg; 1968 Jun; 28(6):530-8. PubMed ID: 4233585
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.
    Phuphanich S; Levin EM; Levin VA
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1769-72. PubMed ID: 6480461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) in high grade malignant gliomas.
    Lambin P; Poortmans P; Menten J; Hamers HP
    Radiother Oncol; 1997 Jun; 43(3):324. PubMed ID: 9215796
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiobiology and clinical application of halogenated pyrimidine radiosensitizers.
    Mitchell JB; Russo A; Cook JA; Straus KL; Glatstein E
    Int J Radiat Biol; 1989 Nov; 56(5):827-36. PubMed ID: 2573682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.